About Us

Top

Caring deeply. Changing lives.™

Biogen is focused on having the greatest impact and benefit for patients worldwide.

Our leadership in multiple sclerosis

Learn more about our aim to improve patient outcomes, commitment to next-generation therapies & stories of those living with MS.

We measure success by our impact on the patients we serve

Every day we ask ourselves one question: Are we truly making a difference in people’s lives?

Nearly four decades of visionary science

One of the world’s oldest independent biotech company began when a group of scientists came together to pursue a new approach to drug discovery.

Leaders with a shared passion

Our leaders share a passion for innovation and visionary science.

Michel Vounatsos
Chief Executive Officer
Susan
Alexander
Executive Vice President, Chief Legal, Corporate Services and Secretary
Paul
Clancy
Executive Vice President, Finance and Chief Financial Officer
Kenneth
DiPietro
Executive Vice President Human Resources
Michael
Ehlers, M.D., Ph.D.
Executive Vice President Research & Development
Paul
McKenzie, Ph.D.
Executive Vice President Pharmaceutical Operations & Technology
Alfred
Sandrock, Jr., M.D., Ph.D.
Executive Vice President and Chief Medical Officer

Corporate governance

Biogen is committed to high ethical standards. We strive to be accountable and transparent to everyone we serve.

A global network makes a world of difference


Our global manufacturing and supply network works to provide innovative, quality medicines wherever and whenever they are needed.

Learn more

Taking a stand on important industry matters

We advocate for government policies to ensure that our scientific advances are able to improve the lives of patients.